MyAverix Finance
F · Healthcare
ARECOR THERAPEUTICS -01 (6UI)
Biotechnology
ARECOR THERAPEUTICS -01 (6UI) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6UI
ARECOR THERAPEUTICS -01 (6UI) — FAQ
What is 6UI's P/E ratio?
The price-to-earnings (P/E) ratio for ARECOR THERAPEUTICS -01 (6UI) is 25.00 (data as of 2026-05-23).
Does ARECOR THERAPEUTICS -01 pay a dividend?
Dividend yield is not available in the current snapshot for ARECOR THERAPEUTICS -01 (6UI). Check the MyAverix Finance app for the latest dividend data.
What sector is ARECOR THERAPEUTICS -01 in?
ARECOR THERAPEUTICS -01 (6UI) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6UI listed on?
6UI is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.